Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20132
20141
20161
20171
20181
20191
20203
20211
20222
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting6
Unknown status4
Terminated3
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NS Pharma, Inc.4
PTC Therapeutics3
Sarepta Therapeutics, Inc.3
Seoul National University Hospital3
ENCell2
GlaxoSmithKline2
BioLeaders Corporation1
BioMarin Pharmaceutical1
Dyne Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne23
Muscular Dystrophies5
Neuromuscular Diseases4
Genetic Diseases, Inborn3
Genetic Diseases, X-Linked3
Muscular Diseases3
Muscular Disorders, Atrophic3
Musculoskeletal Diseases3
Nervous System Diseases3
Amyotrophic Lateral Sclerosis1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.